Drug labeling initiative - cder support

Active Awarded Last action

Contract number
75F40126F19012
Awardee
Awarding agency
Obligated
$5,692,682

Award facts

Contract value 100% obligated
$5,692,681.70 Current and potential, with all options
Completion date 7% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
B528 Special Studies/Analysis- Regulatory
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration issued a BPA call to Deloitte Consulting LLP on September 30, 2026, with a ceiling value of $5,692,681.70 for drug labeling initiative support to the Center for Drug Evaluation and Research. Performance occurs in Silver Spring, Maryland, with an ultimate completion date of September 29, 2027. The call is firm fixed price with no set-aside. No Service Contract Inventory data is reported for this call.

Quick answers

Who was awarded contract 75F40126F19012?

75F40126F19012 was awarded to Deloitte Consulting LLP by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.

How much is contract 75F40126F19012 worth?

The government has obligated $5,692,682 on 75F40126F19012.

Is contract 75F40126F19012 an order under another contract?

Yes. 75F40126F19012 is a BPA call under 75F40122A00018, a blanket purchase agreement.

Was contract 75F40126F19012 competed?

The extent of competition for 75F40126F19012 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award